Resmed Inc (RMD) Stock Price, Quote & News

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858-836-5000

Website: www.resmed.com

Address:

9001 Spectrum Center Boulevard, San Diego, United States

StockAnalyst_SA Jan. 6 at 11:25 AM

$KRKNF — Why $5 Matters Full analysis here! It's free👉 @StockAnalyst_SA (No noise !!) Crossing $5 flips perception: <$5 → OTC/penny stock, >$5 → investable micro-cap. Tighter spreads, better liquidity, lower “casino premium.” Real impact: credibility, procurement cycles, and access improve as institutional investors pay attention. TSX Main Board: Kraken meets market cap, revenue, profitability; only cash flow consistency remains. Stabilized FY25 cash flow → realistic H1 2026 uplisting. Institutional Base: TSX listing opens doors for Canadian institutions restricted from OTC. NASDAQ: Possible but secondary; requires SEC registration, structural changes, and time. Holding >$5 doesn’t guarantee gains, but amplifies every future catalyst: uplisting, coverage, institutional demand. $UI $RMD $SYY $TSLA

0 · Reply

Jacob6444 Jan. 5 at 8:07 PM

@Gillcorsh just imagine the specific company that would stand to lose A LOT if/when this company success with their osa drug… $RMD has no interesting in this company succeeding unless they own it. They are undoubtedly shorting the shit out of this and probably other companies too. Just hold tight yall $IXHL

2 · Reply

protrdr07 Jan. 4 at 10:47 PM

$RMD Does anyone here think RMD buys IXHL ? Just curious what current investors think.

1 · Reply

Dirk1969 Jan. 4 at 9:48 PM

$VVOS buy out $RMD ? Lol

0 · Reply

DavidBreazeale531 Jan. 2 at 2:59 PM

$RMD $SNDK $ASX $MT $MCHP Great finish

0 · Reply

ZacksResearch Dec. 31 at 6:00 AM

$BSX vs. $RMD — which medical device stock has the edge right now? 👀 This head-to-head breakdown puts Boston Scientific and ResMed side by side to see which one stacks up better at this moment — no fluff, just a clear comparison. Find out which stock looks stronger now 👉 https://www.zacks.com/stock/news/2810055/bsx-vs-rmd-which-medical-device-stock-is-the-stronger-play-now?cid=sm-stocktwits-2-2810055-teaser-26710&ADID=SYND_STOCKTWITS_TWEET_2_2810055_TEASER_26710

0 · Reply

ZacksResearch Dec. 30 at 1:44 PM

$BSX or $RMD — which medical device stock is the better buy? 🤔 BSX benefits from growth in cardiovascular and MedSurg segments supported by acquisitions, while RMD sees demand in mask portfolio and AI advancements, focusing on resupply and operational leverage. Notably, BSX has a Zacks Rank #2 (Buy) vs. RMD’s Rank #3 (Hold). Discover the full comparison here 👉 https://www.zacks.com/stock/news/2810055/bsx-vs-rmd-which-medical-device-stock-is-the-stronger-play-now?cid=sm-stocktwits-2-2810055-body-26722&ADID=SYND_STOCKTWITS_TWEET_2_2810055_BODY_26722

0 · Reply

ZacksResearch Dec. 30 at 12:44 PM

Why $DXCM, $RMD, and $MASI could benefit from financial incentives in 2026! 🚀 💰 Higher HSA contribution limits mean more pre-tax savings for devices like CGMs and PAPs. 🔼 Rising Medicare premiums encourage the use of tech for cost-effective chronic disease management. Discover how these stocks are positioned to benefit 👉 https://www.zacks.com/stock/news/2810011/3-stocks-likely-to-gain-from-rising-hsa-contribution-medicare-premium?cid=sm-stocktwits-2-2810011-body-26697&ADID=SYND_STOCKTWITS_TWEET_2_2810011_BODY_26697

0 · Reply

ZacksResearch Dec. 30 at 11:44 AM

💰 Policy tailwinds hitting healthcare — here’s the quiet beneficiary trade. Rising HSA contribution limits and higher Medicare premiums in 2026 could boost demand for chronic care devices, putting $DXCM, $RMD, and $MASI in a favorable spot as patients and providers spend more on long-term care needs. See how these policy shifts could play out 👉 https://www.zacks.com/stock/news/2810011/3-stocks-likely-to-gain-from-rising-hsa-contribution-medicare-premium?cid=sm-stocktwits-2-2810011-teaser-26695&ADID=SYND_STOCKTWITS_TWEET_2_2810011_TEASER_26695

0 · Reply

ELTee227 Dec. 26 at 10:05 PM

$RMD

0 · Reply

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Dec 8, 2025, 9:03 PM EST - 4 weeks ago

Top 50 High-Quality Dividend Growth Stocks For December 2025

ACN ALLE APH DHI DPZ FDS GGG

Dec 8, 2025, 9:00 AM EST - 4 weeks ago

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

Nov 24, 2025, 2:15 PM EST - 6 weeks ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDXX

Nov 17, 2025, 5:24 PM EST - 7 weeks ago

ResMed: Safe Bet For A Recession Environment

Oct 31, 2025, 9:24 AM EDT - 2 months ago

These Analysts Revise Their Forecasts On ResMed Following Q1 Results

Oct 30, 2025, 10:16 PM EDT - 2 months ago

ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript

Oct 30, 2025, 4:05 PM EDT - 2 months ago

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Oct 9, 2025, 4:05 PM EDT - 3 months ago

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

Oct 3, 2025, 10:46 AM EDT - 3 months ago

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 23, 2025, 11:53 AM EDT - 3 months ago

ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 16, 2025, 4:05 PM EDT - 4 months ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Sep 8, 2025, 9:00 PM EDT - 4 months ago

The sleep economy is 'having a moment', says medical equipment firm Resmed

Sep 6, 2025, 12:18 PM EDT - 4 months ago

Top 50 High-Quality Dividend Stocks For September 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 3, 2025, 4:15 PM EDT - 4 months ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Aug 27, 2025, 9:00 AM EDT - 4 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Aug 27, 2025, 7:43 AM EDT - 4 months ago

ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows

Aug 18, 2025, 4:15 PM EDT - 5 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Aug 6, 2025, 11:50 AM EDT - 5 months ago

Top 50 High-Quality Dividend Stocks For August 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Aug 1, 2025, 2:16 PM EDT - 5 months ago

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

Jul 31, 2025, 9:39 PM EDT - 5 months ago

ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

Jul 31, 2025, 4:53 PM EDT - 5 months ago

Resmed beats quarterly profit estimates on strong demand for sleep devices

Jul 31, 2025, 4:05 PM EDT - 5 months ago

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Jul 30, 2025, 6:08 AM EDT - 5 months ago

Spot Outliers Like ResMed Early with Money Flows

Jul 1, 2025, 9:02 PM EDT - 6 months ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ ELV GPN

Jul 1, 2025, 4:05 PM EDT - 6 months ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

Jun 9, 2025, 5:38 AM EDT - 7 months ago

ResMed: A Sleeping Giant Hiding In Plain Sight

Jun 2, 2025, 10:00 AM EDT - 7 months ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR

May 15, 2025, 9:00 AM EDT - 8 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 2, 2025, 11:21 AM EDT - 8 months ago

Top 15 High-Growth Dividend Stocks To Consider For May 2025

AMAT APH DKS DPZ GPN INTU LRCX

May 1, 2025, 9:00 AM EDT - 8 months ago

Resmed Acquires VirtuOx

Apr 24, 2025, 3:24 PM EDT - 9 months ago

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

Apr 24, 2025, 5:12 AM EDT - 9 months ago

ResMed: Cornering The Market In Sleep Solutions

Apr 23, 2025, 7:16 PM EDT - 9 months ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 5:08 PM EDT - 9 months ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 4:05 PM EDT - 9 months ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 21, 2025, 5:00 PM EDT - 9 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 3, 2025, 9:00 AM EDT - 9 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 2, 2025, 4:05 PM EDT - 10 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Apr 2, 2025, 2:12 AM EDT - 10 months ago

My Top 15 High-Growth Dividend Stocks For April 2025

AMAT APH DPZ GPN INTU LRCX MPWR

Mar 19, 2025, 8:00 AM EDT - 10 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 11, 2025, 9:00 AM EDT - 10 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Mar 3, 2025, 4:34 PM EST - 11 months ago

My Top 15 High-Growth Dividend Stocks For March 2025

APH DPZ GPN INTU KLAC LRCX MPWR

Feb 26, 2025, 3:00 AM EST - 11 months ago

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Feb 11, 2025, 4:30 AM EST - 11 months ago

Jan De Witte joins GHO Capital as Operating Partner

IART

Feb 10, 2025, 10:38 AM EST - 11 months ago

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

Feb 3, 2025, 12:59 PM EST - 1 year ago

Stock Of The Day: Trading The Range In ResMed

Jan 30, 2025, 9:10 PM EST - 1 year ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 5:21 PM EST - 1 year ago

ResMed beats quarterly profit estimates on demand for sleep disorder devices

Jan 30, 2025, 4:05 PM EST - 1 year ago

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

StockAnalyst_SA Jan. 6 at 11:25 AM

0 · Reply

Jacob6444 Jan. 5 at 8:07 PM

2 · Reply

protrdr07 Jan. 4 at 10:47 PM

$RMD Does anyone here think RMD buys IXHL ? Just curious what current investors think.

1 · Reply

Dirk1969 Jan. 4 at 9:48 PM

$VVOS buy out $RMD ? Lol

0 · Reply

DavidBreazeale531 Jan. 2 at 2:59 PM

$RMD $SNDK $ASX $MT $MCHP Great finish

0 · Reply

ZacksResearch Dec. 31 at 6:00 AM

0 · Reply

ZacksResearch Dec. 30 at 1:44 PM

0 · Reply

ZacksResearch Dec. 30 at 12:44 PM

0 · Reply

ZacksResearch Dec. 30 at 11:44 AM

0 · Reply

ELTee227 Dec. 26 at 10:05 PM

$RMD

0 · Reply

MicroServiceM Dec. 25 at 5:15 AM

$RMD Long‑horizon outcomes depend on management’s ability to convert scale into defensible margin expansion, with outcomes shaped by timing and discipline. Outcomes hinge on delivery, not scale.

0 · Reply

JarvisFlow Dec. 18 at 1:04 PM

Stifel updates rating for ResMed ( $RMD ) to Hold, target set at 270 → 260.

0 · Reply

St0ckJuggler Dec. 16 at 1:24 PM

$RMD medtech sleep-apnea leader, holding a wide base where a volume breakout can confirm the next leg

0 · Reply

JarvisFlow Dec. 16 at 11:21 AM

Baird has updated their rating for ResMed ( $RMD ) to Neutral with a price target of 275.

0 · Reply

BillionerOfKing Dec. 16 at 9:57 AM

$RMD Current Stock Price: $253.16 Contracts to trade: $250 RMD Dec 19 2025 Call Entry: $3.91 Exit: $5.51 ROI: 41% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

skepticalbee Dec. 10 at 7:35 PM

$IXHL $RMD Really? Given the intrisically intellectual nature of your post, I'm very eager to hear your logic for this prediction. Care to share?

1 · Reply

skepticalbee Dec. 10 at 7:27 PM

$IXHL ResMed ($RMD) has annual revenue of over $5 billion, and a current market cap of $36 billion. Does anyone think they might want to take steps to protect this financial empire by making some sort of deal with IXHL, a major disrupter in the multi-billion dollar OSA market? Just putting this back out there for the newbies and others who might have lost sight of this math.

0 · Reply

IldijanaMM Dec. 10 at 1:25 PM

$IXHL Look at $RMD going in the pre market! 👀

1 · Reply

IldijanaMM Dec. 10 at 10:10 AM

$RMD Can we see a M&A with IXHL that got the worlds best drug for sleep apnea, that just got a Fast track from FDA? I mean 83% reduction in phase 2/3 and zero side effects 🤔 And we moving to Dubai just beside your office!

1 · Reply

Chapman211 Dec. 10 at 2:49 AM

$IXHL $RMD up 12 dollars since close. Crazy. Hopefully we follow and see a nice bounce up in the pm tomorrow morning.

1 · Reply

ZacksResearch Dec. 9 at 11:29 AM

$RMD about to heat up? This FDA clearance could be the catalyst traders have been waiting for. The headline points straight to RMD getting a boost from its AI-enabled Smart Comfort winning FDA clearance — and that kind of validation can shift sentiment fast. See what’s driving the setup here 👉 https://www.zacks.com/stock/news/2801393/rmd-stock-set-to-gain-from-fda-clearance-of-ai-enabled-smart-comfort?cid=sm-stocktwits-2-2801393-teaser-23904&ADID=SYND_STOCKTWITS_TWEET_2_2801393_TEASER_23904

0 · Reply

ELTee227 Dec. 8 at 4:14 PM

$RMD Bouncy Bouncy. Up and down she does.

0 · Reply

Market Cap	35.73B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
EPS (ttm)	N/A
PE Ratio	24.33
Forward PE	22.23
Profit Margin	27.22%
Debt to Equity Ratio	0.07

Volume	735,290
Avg Vol	1,082,020
Day's Range	N/A - N/A
Shares Out	145.94M
Stochastic %K	91%
Beta	0.88
Analysts	Sell
Price Target	$289.38